Maia Biotechnology News - MAIA

Company Name	Stock Ticker Symbol	Market	Type
Maia Biotechnology Inc	MAIA	AMEX	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.12	4.46%	2.81	18:11:44

Open Price	Low Price	High Price	Close Price	Prev Close
2.61	2.61	2.75	2.68	2.69

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/23/2024	08:51	BW	MAIA Biotechnology Announces $1.00 Million Private Placement
4/05/2024	08:01	BW	MAIA Biotechnology to Present at Two Investor Conferences in..
3/28/2024	15:00	BW	MAIA Biotechnology Announces Share Purchases by Directors..
3/26/2024	15:00	BW	MAIA Biotechnology Announces Share Purchase by Director..
3/26/2024	08:01	BW	MAIA Biotechnology Announces $1.33 Million Private Placement
3/22/2024	15:00	BW	MAIA Biotechnology Announces Share Purchase by Director Stan..
3/21/2024	15:00	BW	MAIA Biotechnology Welcomes Prominent Medical Oncology..
3/08/2024	16:15	EDGAR2	Form 8-K - Current report
3/07/2024	09:45	BW	MAIA Biotechnology to Participate in the 36th Annual ROTH..
3/06/2024	11:04	BW	MAIA Biotechnology and Nationwide Children’s Hospital..
3/06/2024	08:48	BW	MAIA Biotechnology Announces Strong Efficacy of THIO as..
3/06/2024	08:00	EDGAR2	Form 8-K - Current report
3/05/2024	08:45	BW	MAIA Biotechnology CEO Details Immuno-Oncology Cancer..
2/27/2024	17:23	EDGAR2	Form 8-K - Current report
2/23/2024	16:17	EDGAR2	Form 8-K - Current report
2/14/2024	17:18	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/14/2024	17:15	EDGAR2	Form 8-K - Current report
2/07/2024	08:01	BW	MAIA Biotechnology Announces Publication in Nature..
1/30/2024	09:00	EDGAR2	Form 8-K - Current report
1/26/2024	16:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/26/2024	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/26/2024	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/24/2024	07:15	BW	MAIA Biotechnology Announces Publication of International..
1/19/2024	21:00	EDGAR2	Form 144 - Report of proposed sale of securities
1/18/2024	06:01	EDGAR2	Form 8-K - Current report
1/17/2024	09:00	BW	MAIA Biotechnology Provides Positive Phase 2 Clinical..
1/05/2024	08:00	BW	MAIA Biotechnology to Present at Biotech Showcase 2024 on..
1/03/2024	21:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	21:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	21:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	21:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	20:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/21/2023	07:00	EDGAR2	Form 8-K - Current report
12/19/2023	07:00	BW	MAIA Biotechnology Announces Dose Selection in THIO-101..
11/29/2023	16:19	EDGAR2	Form D - Notice of Exempt Offering of Securities
11/17/2023	15:52	BW	MAIA Biotechnology Announces Closing of $4 Million..
11/17/2023	09:09	EDGAR2	Form 8-K - Current report
11/17/2023	09:06	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/16/2023	17:26	EDGAR2	Form 8-K - Current report
11/15/2023	09:35	BW	MAIA Biotechnology Announces $4 Million Registered Direct..
11/15/2023	08:42	EDGAR2	Form 8-K - Current report
11/15/2023	08:41	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/13/2023	06:07	EDGAR2	Form 8-K - Current report
11/10/2023	07:01	BW	FDA Grants Orphan Drug Designation to MAIA Biotechnology for..
11/07/2023	08:15	BW	MAIA Biotechnology Reports Third Quarter 2023 Financial..
11/07/2023	08:05	EDGAR2	Form 8-K - Current report
11/07/2023	08:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/30/2023	17:24	EDGAR2	Form 8-K - Current report
10/30/2023	08:41	BW	MAIA Biotechnology Reveals Higher Anticancer Potency of..
10/24/2023	08:00	BW	MAIA Biotechnology Announces 100% Disease Control in..